Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113200933A details a novel one-pot asymmetric synthesis of benzocarboxylates using chiral urea catalysis, offering high enantioselectivity and streamlined manufacturing for API intermediates.
Discover a novel metal-free synthesis method for 3-acyl indoles via nucleophilic organocatalysis. Achieve high purity and cost reduction in API manufacturing with scalable processes.
Patent CN105879905A introduces a novel chiral phosphine catalyst enabling high enantioselectivity in cross Rauhut-Currier reactions, offering significant supply chain and cost advantages.
Patent CN110950793B details a metal-free, biphasic synthesis of chiral diarylindolemethanes with high stereoselectivity, offering cost-effective supply chain solutions.
Patent CN115677605A reveals a mild 5-step route for S-Fluralaner. Achieve higher ee values and yields with cost-effective chiral thiourea catalysis for veterinary markets.
Novel cyclic phosphine catalyst Le-Phos enables high-yield asymmetric gamma-addition. Efficient synthesis route reduces costs for API manufacturing.
Discover the novel organocatalytic synthesis of chiral thiopyranoindolobenzothiophene sulfones. High stereoselectivity and mild conditions for efficient pharmaceutical intermediate manufacturing.
Patent CN102153557A reveals ethylenediamine-based NHC salts for chiral synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Discover efficient one-pot synthesis of phosphoramide derivatives for catalyzing gamma-delta-unsaturated ketone production. Enhanced yield and reduced reaction time for industrial scale-up.
Novel bisaryl substituted catalyst enables high stereoselectivity. Reduces manufacturing costs and ensures supply chain reliability for complex pharmaceutical intermediate production.
Patent CN101525291A details a water-based organocatalytic route for chiral bicyclics, offering high enantioselectivity and reduced environmental impact for pharmaceutical manufacturing.
Novel 5-step synthesis route for chiral phenylglycine catalysts. High yield, mild conditions, scalable for pharma intermediates.
Novel patent CN116655694A enables metal-free synthesis. Delivers high purity catalysts for asymmetric reactions with reduced supply chain complexity and cost.
Patent CN102766058A details a novel organocatalytic route for photoactive alpha-amino acids, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN109529928B reveals a novel methyl-bridge catalyst system enabling high-yield azoxystrobin synthesis with reduced energy consumption and superior process control.
Patent CN108722480A reveals a novel Tröger's Base Schiff base catalyst offering high selectivity and mild conditions for cost reduction in fine chemical manufacturing.
Patent CN108409746B details a novel chiral phosphoric acid catalyzed synthesis of spirooxindoles, offering a metal-free route for reliable pharmaceutical intermediate suppliers.
Novel synthesis of 1,3-disubstituted pyrazoles as AR antagonists. Efficient route for pharma intermediates with scalable steps and high purity.
Patent CN116813659A introduces a threonine-based chiral catalyst enabling high enantioselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.
Patent CN103450044A reveals a PEG-200 catalyzed route for aromatic azo compounds, offering a metal-free, high-yield alternative for pharma intermediates.